Contract 36F79718D0547
Taro Pharmaceuticals U.S.A., Inc. · Department Of Veterans Affairs · September 6, 2018
Taro Pharmaceuticals U.S.A., Inc. was awarded a federal contract by Department Of Veterans Affairs on September 6, 2018 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 38 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 12, 2025. If all options are exercised, the contract could reach $7.80 million.
Contract details
- PIID
- 36F79718D0547
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 6, 2018
- Latest action
- May 12, 2025
Description
CONTRACT CANCEL
Modification timeline
-
May 12, 2025Mod P00042$0
-
April 21, 2025Mod P00041PRODUCT DELETIONS$0
-
April 1, 2025Mod P000402025 SUBPLAN$0
-
January 30, 2025Mod P00039DELETIONS$0
-
November 22, 2024Mod P00037PL 2025$0
-
August 20, 2024Mod P00036SHORT TERM EXT.$0
-
May 16, 2024Mod P00035DELETION$0
-
April 29, 2024Mod P00034ADD$0
-
April 23, 2024Mod P00033SUBPLAN$0
-
January 9, 2024Mod P00032DELETIONS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79718D0547?
Contract 36F79718D0547 is a federal contract awarded to Taro Pharmaceuticals U.S.A., Inc. by Department Of Veterans Affairs on September 6, 2018 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 38 times since the base award.
Who won contract 36F79718D0547?
Taro Pharmaceuticals U.S.A., Inc. won contract 36F79718D0547 from Department Of Veterans Affairs.
How much is contract 36F79718D0547 worth?
Contract 36F79718D0547 has obligated $0 to date but carries a potential ceiling of $7.80 million if fully funded and all options are exercised.